Luke Evnin, 10% Owner: TCR2 Therapeutics TCRR Sell · Filed 23/05/24

Trade details

Type: Insider sale
Amount: $131,919.6
Shares · price: 70,170 sh · $1.88 a share
Held after: 304,001 sh
Stock: TCR2 Therapeutics TCRR
Person: Luke Evnin10% Owner
Trade date: 23/05/22
Filed: 23/05/24
Days to filing: 2 days

Sold 18.8% of holdings

Share of holding sold: 18.8%

TCR2 Therapeutics trades, last 26 weeks

What else happened in TCR2 Therapeutics around then

Filed or reported within 30 days of the trade day · 23/04/22~23/06/21

Luke Evnin's recent trades

Luke EvninDirector
Sell10b5-1 planWerewolf Therapeutics
Sell10b5-1 plan
Werewolf Therapeutics
HOWL
$47.1K
157,084 sh
$47.1K
Filed 06/29
Traded 06/29
Luke EvninDirector
Sell10b5-1 planWerewolf Therapeutics
Sell10b5-1 plan
Werewolf Therapeutics
HOWL
$28.5K
76,928 sh
$28.5K
Filed 06/10
Traded 06/09
Luke EvninDirector
Sell10b5-1 planWerewolf Therapeutics
Sell10b5-1 plan
Werewolf Therapeutics
HOWL
$24.2K
60,547 sh
$24.2K
Filed 06/08
Traded 06/08
Luke EvninDirector
Sell10b5-1 planWerewolf Therapeutics
Sell10b5-1 plan
Werewolf Therapeutics
HOWL
$9,978
24,946 sh
$9,978
Filed 06/08
Traded 06/05
Luke EvninDirector
Sell10b5-1 planWerewolf Therapeutics
Sell10b5-1 plan
Werewolf Therapeutics
HOWL
$8,832
20,072 sh
$8,832
Filed 06/08
Traded 06/04